Our Backbone: Cancer Centres
The backbone of the 3CTN initiative are the member sites that collaborate and communicate via our innovative Network structure.
Our Voice: Patient Representatives
Patient Representatives can contribute a crucial perspective to clinical trials by providing feedback, insight, expertise and support towards trial activities and initiatives.
Coordinating Centre
At the pinnacle of the Network, The 3CTN Coordinating Centre acts as the leadership and communication hub for the Network and is responsible for supporting and coordinating activities at the Network sites, in order to reach the Network’s goals and objectives.
- Scientific Director
- Associate Scientific Director
- Associate Scientific Director
- Executive Director
- Director, Information Technology
- Manager, Operations
- Project Financial Analyst
- Manager, Portfolio and Informatics
- Portfolio Data Coordinator
- Project Lead
Our Governance
Each committee in our governance brings expert knowledge at a high level, which is crucial to the success of 3CTN as it provides a link to the broader Canadian cancer research environment with the aim of maintaining 3CTN’s relevance and sustainability.
Scientific Advisory Board
- Chair, Breast International Group
- Professor, Division of Gynecologic Oncology, University of British Columbia
- Patient Representative
- Patient Representative
- Assistant Director, Institute of Cancer Research, Canadian Institutes of Health Research
- Executive Director, 3CTN
- Scientific Director, 3CTN
Funders Oversight Committee
- Vice President, Cancer Control Canadian Partnership Against Cancer
- Vice President, Cancer Systems, Performance and Innovation, Canadian Partnership Against Cancer
- Emeritus Professor of Medical Oncology, Princess Margaret Cancer Centre
- Vice President, Program Investment (Acting), Alberta Cancer Foundation
- Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)
- Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency
- Executive Director, Eastern Regional Health Authority
- Patient Representative
- Director, Research & Innovation, Eastern Regional Health Authority
- Manager, Clinical Trials Unit, CancerCare Manitoba
- Deputy Director and Head, Clinical Translation, Ontario Institute for Cancer Research
- Executive Director, 3CTN
- Scientific Director, 3CTN
Management and Executive (*) Committee
- Emeritus Professor of Medical Oncology, Princess Margaret Cancer Centre
- Scientific Director, 3CTN
- Provincial Director, Systemic Therapy Clinical Trials, BC Cancer Agency
- Patient Representative and Chair, Melanoma Network of Canada
- Scientific Director, Q-Clinical Research Organization in Cancer (Q-CROC)
- Manager, Cancer Clinical Research Team, Kingston Health Sciences Centre
- Emeritus Professor, Queen’s University
- Vice President, Clinical Operations & Drug Development, Qu Biologics
- Medical Oncologist, Nova Scotia Cancer Centre
- Radiation Oncology, London Regional Cancer Program
- Clinical Assistant Professor, Department of Oncology, Tom Baker Cancer Centre
- Division Head, Haematology/Oncology, The Hospital for Sick Children
- Medical Director, Community Oncology, CancerCare Manitoba
- Physician Director, Clinical Trials, Dr. H. Bliss Murphy Cancer Centre
- Executive Director, 3CTN
- Director, Information Technology, 3CTN
Our Operating/Advisory Committees
Portfolio Committee
This team is responsible for reviewing the criteria for trial entry into the Portfolio and metrics for trial retention within the Portfolio; and reviewing the trial Portfolio for scientific merit, priority, performance and strategic balance to cover the range of trials of interest/relevance to Canadians and the Canadian health care system.
- Emeritus Professor, Queen’s University
- Medical Oncologist, BC Cancer Agency, Vancouver Clinic
- Provincial Leader, Clinical Research, Saskatchewan Cancer Agency
- Medical Oncologist, CHU de Quebec
- Patient Representative, British Columbia
- Associate Professor, Department of Pediatrics, McMaster University
- Manager, Clinical Research, Eastern Health
- Radiation Oncologist, Juravinski Cancer Centre
- Scientific Director, 3CTN
- Executive Director, 3CTN
- Portfolio and Informatics Manager, 3CTN
- Portfolio Data Coordinator, 3CTN
Performance Strategy Team
This team is responsible for evaluating Network performance, identifying problems and proposing new initiatives, tools to improve the efficiency and quality of trial activities, improvements to and competencies of clinical trial staff through education, training and mentoring and greater patient access to trials.
- Project Manager, Clinical Research Network, Q-CROC
- Director, Clinical Research, Saskatchewan Cancer Agency
- Clinical Trials Manager, CancerCare Manitoba
- Director, Innovation and Research and Clinical Trials, Grand River Hospital
- Clinical Manager, Kingston Health Sciences Centre
- Clinical Trials Manager, Juravinski Cancer Centre
- Manager, Trial Management Group, Canadian Cancer Trials Group
- Research Ethics Officer, Ontario Institute for Cancer Research
- Manager, Clinical Trials & Clinical Research, Vancouver Island Centre, BC Cancer
- Patient Representative
- Executive Director, 3CTN
Patient Representative Advisory Committee (PRAC)
The PRAC is a team of 3CTN Patient Representatives and 3CTN CC staff with the focus of providing feedback, insight, expertise and support to the Network.
- Manitoba
- Ontario
- Quebec
- Quebec
- Newfoundland
- Ontario
- Quebec
- Executive Director, 3CTN
Our Partners
Our Canada-wide initiative is made possible by contributions from our funders and through collaborations with organizations who share our vision for the cancer clinical trial landscape.
Funding Partners
Collaborators
